MFDS — authorised 30 March 2016
- Marketing authorisation holder: GENTIUM SRL
- Status: likely_approved
🇰🇷 Defitelio in South Korea
MFDS authorised Defitelio on 30 March 2016
Marketing authorisation
Defitelio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Defitelio approved in South Korea?
Yes. MFDS authorised it on 30 March 2016.
Who is the marketing authorisation holder for Defitelio in South Korea?
GENTIUM SRL holds the South Korean marketing authorisation.